Projects - Drug Development Technology

Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

X

Advertise with us

Gamifant

Gamifant (emapalumab-lzsg) for Primary Haemophagocytic Lymphohistiocytosis

Gamifant® (emapalumab-lzsg) is an interferon gamma (IFNγ) blocking antibody indicated for the treatment of primary haemophagocytic lymphohistiocytosis (HLH) in paediatric and adult patients.

Tradjenta Indicated for the Treatment of Type II Diabetes

Blincyto® (blinatumomab) for the Treatment of B-cell Precursor Acute Lymphoblastic Leukaemia

Lorbrena

Lorbrena (lorlatinib) for ALK-Positive Metastatic Non-Small Cell Lung Cancer

Dupixent (dupilumab) for the Treatment of Atopic Dermatitis

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Filter by:

Projects by Region: Europe

Cablivi (caplacizumab) for the Treatment of Acquired Thrombotic Thrombocytopenic Purpura

Cablivi (caplacizumab) is a bivalent anti-Von Willebrand factor (vWF) nanobody indicated for the treatment of...
Read More...

Carnexiv (carbamazepine) for the Treatment of Certain Seizure Types in Adults

Carnexiv (carbamazepine) is an injectable formulation developed by Lundbeck for partial, generalised tonic-clonic seizures in...
Read More...